Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medicure (MCUJF) Income towards Parent Company (2016 - 2025)

Medicure has reported Income towards Parent Company over the past 17 years, most recently at -$3.0 million for Q4 2025.

  • For Q4 2025, Income towards Parent Company fell 1250.89% year-over-year to -$3.0 million; the TTM value through Dec 2025 reached -$4.9 million, down 1181.76%, while the annual FY2025 figure was -$5.1 million, 584.24% down from the prior year.
  • Income towards Parent Company for Q4 2025 was -$3.0 million at Medicure, down from -$922826.5 in the prior quarter.
  • Over five years, Income towards Parent Company peaked at $1.5 million in Q4 2021 and troughed at -$3.0 million in Q4 2025.
  • A 5-year average of -$208117.8 and a median of -$83312.1 in 2023 define the central range for Income towards Parent Company.
  • Biggest five-year swings in Income towards Parent Company: skyrocketed 3284.04% in 2021 and later crashed 1250.89% in 2025.
  • Year by year, Income towards Parent Company stood at $1.5 million in 2021, then tumbled by 77.22% to $334463.1 in 2022, then tumbled by 457.97% to -$1.2 million in 2023, then soared by 81.29% to -$224060.8 in 2024, then crashed by 1250.89% to -$3.0 million in 2025.
  • Business Quant data shows Income towards Parent Company for MCUJF at -$3.0 million in Q4 2025, -$922826.5 in Q3 2025, and -$483547.4 in Q2 2025.